title: Reversible accumulation of lipofuscin-like inclusions in the retinal pigment epithelium.
abstract: OBJECTIVE
  The amounts of autofluorescent lysosomal storage bodies, known as lipofuscin, increase during senescence in the retinal pigment epithelia (RPEs) of mammalian eyes. This increase in lipofuscin content may result from a failure of the RPE to dispose of any lipofuscin constituents once they have formed. Alternatively, the RPE may eliminate lipofuscin but at a rate insufficient to prevent its accumulation. Experiments were conducted to distinguish between these two possibilities.
  
  
  METHODS
  Albino rats were given intravitreal injections of the protease inhibitor leupeptin, which induces a rapid accumulation of lipofuscin-like inclusions in the RPE. The amount of these inclusions in the RPE was monitored as a function of time after the leupeptin treatment with quantitative ultrastructural analysis. In addition, the intensity of lipofuscin-specific fluorescence in the RPE was monitored over the same time period with the use of quantitative microfluorometry. These parameters were also followed in untreated control eyes of age-matched animals.
  
  
  RESULTS
  A single leupeptin injection resulted in a rapid massive accumulation of electron-dense inclusion bodies in the RPE. These inclusions appeared to be derived primarily from phagocytosed photoreceptor outer segments. Accompanying the accumulation of these inclusions was a significant increase in lipofuscin-specific fluorescence in the RPE. Over a 12-week period after the leupeptin treatment, the amounts of inclusion material and the fluorescence intensities returned to normal levels.
  
  
  CONCLUSIONS
  These findings suggest that the age-related increase in RPE lipofuscin content results from an imbalance in the rates of lipofuscin formation and disposal rather than from a complete absence of a disposal mechanism. The results imply that turnover of lipofuscin constituents may be rapid relative to the animals' life span. Thus, it may be possible to slow or reverse the age-related increase in RPE lipofuscin content by either inhibiting the processes involved in lipofuscin formation or enhancing the disposal processes.
authors.affiliation: Mason Eye Institute, University of Missouri School of Medicine, Columbia 65212, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Katz
authors.forename: L M
authors.initials: LM
authors.lastname: Rice
authors.forename: C L
authors.initials: CL
authors.lastname: Gao
mesh_terms: D000375:Aging / Q000502:physiology; D000818:Animals; D005136:Eye Proteins / Q000378:metabolism*; D002479:Inclusion Bodies / Q000378:metabolism* / Q000648:ultrastructure; D007267:Injections; D007976:Leupeptins / Q000494:pharmacology*; D008062:Lipofuscin / Q000378:metabolism*; D008297:Male; D008856:Microscopy, Fluorescence; D010857:Pigment Epithelium of Eye / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D011916:Rats, Inbred F344; D014822:Vitreous Body
chemical_list: D005136:Eye Proteins; D007976:Leupeptins; D008062:Lipofuscin; C032854:leupeptin